{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:09:32Z","timestamp":1779206972323,"version":"3.51.4"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["12102120"],"award-info":[{"award-number":["12102120"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14103121"],"award-info":[{"award-number":["14103121"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14103420"],"award-info":[{"award-number":["14103420"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14109721"],"award-info":[{"award-number":["14109721"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["T12-201\/20-R"],"award-info":[{"award-number":["T12-201\/20-R"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["4054660"],"award-info":[{"award-number":["4054660"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2019B1515120089"],"award-info":[{"award-number":["2019B1515120089"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0800802"],"award-info":[{"award-number":["2018YFA0800802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["RC-ICRS\/19\u201320\/01"],"award-info":[{"award-number":["RC-ICRS\/19\u201320\/01"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bcp.2023.115694","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T21:27:14Z","timestamp":1689888434000},"page":"115694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The role of sclerostin in lipid and glucose metabolism disorders"],"prefix":"10.1016","volume":"215","author":[{"given":"Hewen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongkang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sifan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0005","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.18632\/oncotarget.12157","article-title":"Sirtuins in glucose and lipid metabolism","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0010","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/ijms21051835","article-title":"The diabetes mellitus\u2013atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 Years","volume":"377","author":"Tabar\u00e9s Seisdedos","year":"2017","journal-title":"N Engl. J. Med."},{"issue":"9945","key":"10.1016\/j.bcp.2023.115694_b0020","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2023.115694_b0025","unstructured":"D. Akram, A. Astrup, T. Atinmo, Obesity: preventing and managing the global epidemic, (2000)."},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0030","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2008-0520","article-title":"Update on obesity","volume":"93","author":"Bessesen","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1467-789X.2004.00144.x","article-title":"Obesity as a disease: no lightweight matter","volume":"5","author":"Conway","year":"2004","journal-title":"Obes. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2023.115694_b0040","first-page":"RA130-47","article-title":"Diabetes mellitus: complications and therapeutics","volume":"12","author":"Tripathi","year":"2006","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus\u2013present and future perspectives","volume":"8","author":"Chen","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b0050","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.7150\/ijms.10001","article-title":"Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention","volume":"11","author":"Wu","year":"2014","journal-title":"Int. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/S0004-27302010000200010","article-title":"Obesity, diabetes mellitus and last but not least, osteoporosis","volume":"54","author":"Paula","year":"2010","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rehab.2016.04.002","article-title":"Osteoarthritis, obesity and type 2 diabetes: the weight of waist circumference","volume":"59","author":"Duclos","year":"2016","journal-title":"Ann. Phys. Rehabil. Med."},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0065","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/dom.13330","article-title":"Bone: another potential target to treat, prevent and predict diabetes","volume":"20","author":"Liu","year":"2018","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s40610-017-0057-7","article-title":"Connecting bone and fat: the potential role for sclerostin","volume":"3","author":"Fairfield","year":"2017","journal-title":"Curr. Mol. Biol. Rep."},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41574-019-0246-y","article-title":"The role of osteoblasts in energy homeostasis","volume":"15","author":"Dirckx","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/me.2003-0227","article-title":"Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists","volume":"18","author":"Avsian-Kretchmer","year":"2004","journal-title":"Mol. Endocrinol."},{"issue":"8 Suppl","key":"10.1016\/j.bcp.2023.115694_b0090","first-page":"15","article-title":"Bone morphogenetic proteins and their antagonists: the sclerostin paradigm","volume":"28","author":"van Bezooijen","year":"2005","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"26","key":"10.1016\/j.bcp.2023.115694_b0100","doi-asserted-by":"crossref","first-page":"24113","DOI":"10.1074\/jbc.M301716200","article-title":"Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity","volume":"278","author":"Kusu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/dbio.2002.0779","article-title":"Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators","volume":"250","author":"Balemans","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bcp.2023.115694_b0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1749-6632.2009.05246.x","article-title":"Dynamics of the transition from osteoblast to osteocyte","volume":"1192","author":"Dallas","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"13","key":"10.1016\/j.bcp.2023.115694_b0115","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0120","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1530\/JME-18-0176","article-title":"Novel actions of sclerostin on bone","volume":"62","author":"Holdsworth","year":"2019","journal-title":"J. Mol. Endocrinol."},{"issue":"23","key":"10.1016\/j.bcp.2023.115694_b0125","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"issue":"13","key":"10.1016\/j.bcp.2023.115694_b0130","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.3390\/ijms21134779","article-title":"Sclerostin and vascular pathophysiology","volume":"21","author":"Catalano","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/biomedicines9010071","article-title":"Identification of sclerostin as a putative new myokine involved in the muscle-to-bone crosstalk","volume":"9","author":"Magar\u00f2","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3803\/EnM.2022.1428","article-title":"Decreased serum level of sclerostin in older adults with sarcopenia","volume":"37","author":"Ahn","year":"2022","journal-title":"Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbrc.2009.01.062","article-title":"NMR structure of the Wnt modulator protein Sclerostin","volume":"380","author":"Weidauer","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.bcp.2023.115694_b0150","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1074\/jbc.M807994200","article-title":"Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation","volume":"284","author":"Veverka","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2023.115694_b0155","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.str.2011.07.005","article-title":"Wnt antagonists bind through a short peptide to the first beta-propeller domain of LRP5\/6","volume":"19","author":"Bourhis","year":"2011","journal-title":"Structure"},{"issue":"Supplement_1","key":"10.1016\/j.bcp.2023.115694_b0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2106\/JBJS.G.01183","article-title":"Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling","volume":"90","author":"ten Dijke","year":"2008","journal-title":"J. Bone Jt. Surg."},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3048","article-title":"Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2\/CBF\u03b2-dependent expression of the Wnt antagonist, sclerostin","volume":"13","author":"Mendoza-Villanueva","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bcp.2023.115694_b0170","article-title":"Drug discovery of DKK1 inhibitors","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115694_b0175","first-page":"209","article-title":"Osteopetrosis with syndactyly; a morphological variant of Albers-Schonberg's disease","volume":"40-B(2)","author":"Truswell","year":"1958","journal-title":"J. Bone Joint Surg. Br."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00016925509170789","article-title":"An uncommon familial systemic disease of the skeleton: hyperostosis corticalis generalisata familiaris","volume":"44","author":"van Buchem","year":"2010","journal-title":"Acta Radiol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0185","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00223-016-0126-6","article-title":"Sclerostin inhibition in the management of osteoporosis","volume":"98","author":"Appelman-Dijkstra","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00018-008-8429-z","article-title":"Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program","volume":"66","author":"Muruganandan","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cell.2007.10.004","article-title":"Developmental origin of fat: tracking obesity to its source","volume":"131","author":"Gesta","year":"2007","journal-title":"Cell"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2023.115694_b0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2106\/JBJS.G.01183","article-title":"Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling","volume":"90","author":"ten Dijke","year":"2008","journal-title":"J. Bone Joint Surg. Am."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0205","first-page":"139","article-title":"Identification of the disease-causing gene in sclerosteosis\u2013discovery of a novel bone anabolic target?","volume":"4","author":"Balemans","year":"2004","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0210","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bone.2013.02.022","article-title":"Regulation of Wnt\/beta-catenin signaling within and from osteocytes","volume":"54","author":"Burgers","year":"2013","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jb\/mvp148","article-title":"Bone morphogenetic protein receptors and signal transduction","volume":"147","author":"Miyazono","year":"2010","journal-title":"J. Biochem."},{"key":"10.1016\/j.bcp.2023.115694_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100678","article-title":"Adipose tissue plasticity and the pleiotropic roles of BMP signaling","volume":"296","author":"Qian","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0225","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/emboj\/19.8.1745","article-title":"Transcriptional control by the TGF-beta\/Smad signaling system","volume":"19","author":"Massague","year":"2000","journal-title":"EMBO J."},{"issue":"6659","key":"10.1016\/j.bcp.2023.115694_b0230","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-beta signalling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"Heldin","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0235","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1091\/mbc.e02-06-0356","article-title":"Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis","volume":"14","author":"Hata","year":"2003","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-5793(00)01655-0","article-title":"Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone)","volume":"475","author":"Sottile","year":"2000","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.bcp.2023.115694_b0245","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrm2066","article-title":"Adipocyte differentiation from the inside out","volume":"7","author":"Rosen","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"17","key":"10.1016\/j.bcp.2023.115694_b0250","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1073\/pnas.0306743102","article-title":"Deletion of PPAR\u03b3 in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance","volume":"102","author":"Jones","year":"2005","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0255","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcb.21319","article-title":"BMP7 promotes adipogenic but not osteo-\/chondrogenic differentiation of adult human bone marrow-derived stem cells in high-density micro-mass culture","volume":"102","author":"Neumann","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0260","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4161\/cc.6.4.3804","article-title":"A role for bone morphogenetic protein-4 in adipocyte development","volume":"6","author":"Bowers","year":"2007","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0265","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00776-004-0815-2","article-title":"Bone morphogenetic protein-2 induces differentiation of multipotent C3H10T1\/2 cells into osteoblasts, chondrocytes, and adipocytes in vivo and in vitro","volume":"9","author":"Date","year":"2004","journal-title":"J. Orthop. Sci."},{"issue":"35","key":"10.1016\/j.bcp.2023.115694_b0270","doi-asserted-by":"crossref","first-page":"13022","DOI":"10.1073\/pnas.0605789103","article-title":"Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene","volume":"103","author":"Bowers","year":"2006","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0275","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/excr.1996.0005","article-title":"Human osteogenic protein-1 induces chondroblastic, osteoblastic, and\/or adipocytic differentiation of clonal murine target cells","volume":"222","author":"Asahina","year":"1996","journal-title":"Exp. Cell Res."},{"issue":"31","key":"10.1016\/j.bcp.2023.115694_b0280","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1073\/pnas.0906266106","article-title":"BMP signaling pathway is required for commitment of C3H10T1\/2 pluripotent stem cells to the adipocyte lineage","volume":"106","author":"Huang","year":"2009","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"7207","key":"10.1016\/j.bcp.2023.115694_b0285","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/nature07221","article-title":"New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure","volume":"454","author":"Tseng","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0290","doi-asserted-by":"crossref","first-page":"C431","DOI":"10.1152\/ajpcell.00290.2013","article-title":"BMP4 and BMP7 induce the white-to-brown transition of primary human adipose stem cells","volume":"306","author":"Elsen","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0295","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.celrep.2016.07.048","article-title":"Bmp4 promotes a brown to white-like adipocyte shift","volume":"16","author":"Modica","year":"2016","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0300","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.celrep.2017.07.020","article-title":"BMP4 gene therapy in mature mice reduces BAT activation but protects from obesity by browning subcutaneous adipose tissue","volume":"20","author":"Hoffmann","year":"2017","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0305","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12013-020-00935-0","article-title":"Contrary roles of Wnt\/\u03b2-catenin signaling in BMP9-induced osteogenic and adipogenic differentiation of 3T3-L1 preadipocytes","volume":"78","author":"Liang","year":"2020","journal-title":"Cell Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0310","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/08977190903512610","article-title":"Effect of BMP-9 and its derived peptide on the differentiation of human white preadipocytes","volume":"28","author":"Lord","year":"2010","journal-title":"Growth Factors"},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0315","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/er.2002-0023","article-title":"Bone morphogenetic proteins, their antagonists, and the skeleton","volume":"24","author":"Canalis","year":"2003","journal-title":"Endocr. Rev."},{"issue":"12","key":"10.1016\/j.bcp.2023.115694_b0320","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0325","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0330","first-page":"357","article-title":"Wnt signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation","volume":"6","author":"Lowik","year":"2006","journal-title":"J. Musculoskel. Neuronal Interact."},{"issue":"52","key":"10.1016\/j.bcp.2023.115694_b0335","doi-asserted-by":"crossref","first-page":"E11238","DOI":"10.1073\/pnas.1707876115","article-title":"Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes","volume":"114","author":"Kim","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0340","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2023.115694_b0345","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0070-2153(06)76004-5","article-title":"Wnt signaling: a key regulator of bone mass","volume":"76","author":"Baron","year":"2006","journal-title":"Curr. Top. Dev. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0350","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0355","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0360","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrrheum.2009.137","article-title":"Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis","volume":"5","author":"Takada","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"34","key":"10.1016\/j.bcp.2023.115694_b0365","doi-asserted-by":"crossref","first-page":"35503","DOI":"10.1074\/jbc.M402937200","article-title":"Wnt10b inhibits development of white and brown adipose tissues","volume":"279","author":"Longo","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5481","key":"10.1016\/j.bcp.2023.115694_b0370","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.289.5481.950","article-title":"Inhibition of adipogenesis by Wnt signaling","volume":"289","author":"Ross","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0375","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bone.2011.08.010","article-title":"Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a beta-catenin-dependent mechanism","volume":"50","author":"Cawthorn","year":"2012","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bcp.2023.115694_b0380","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.2337\/db08-1770","article-title":"Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation","volume":"58","author":"Isakson","year":"2009","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0385","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ydbio.2005.09.045","article-title":"Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium","volume":"288","author":"Arango","year":"2005","journal-title":"Dev. Biol."},{"issue":"Pt 16","key":"10.1016\/j.bcp.2023.115694_b0390","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1242\/jcs.079699","article-title":"Adipogenesis at a glance","volume":"124","author":"Lowe","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2023.115694_b0395","doi-asserted-by":"crossref","first-page":"8892300","DOI":"10.1155\/2020\/8892300","article-title":"Molecular mechanism of stem cell differentiation into adipocytes and adipocyte differentiation of malignant tumor","volume":"2020","author":"Zhang","year":"2020","journal-title":"Stem Cells Int."},{"issue":"7","key":"10.1016\/j.bcp.2023.115694_b0400","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.cell.2012.11.027","article-title":"Role of TAZ as mediator of Wnt signaling","volume":"151","author":"Azzolin","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0405","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/cdd.2014.8","article-title":"Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation","volume":"21","author":"Byun","year":"2014","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0410","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/cc.5.2.2362","article-title":"TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation","volume":"5","author":"Hong","year":"2006","journal-title":"Cell Cycle"},{"issue":"5737","key":"10.1016\/j.bcp.2023.115694_b0415","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1110955","article-title":"TAZ, a transcriptional modulator of mesenchymal stem cell differentiation","volume":"309","author":"Hong","year":"2005","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bcp.2023.115694_b0420","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/MCB.01874-07","article-title":"TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway","volume":"28","author":"Lei","year":"2008","journal-title":"Mol. Cell Biol."},{"issue":"20","key":"10.1016\/j.bcp.2023.115694_b0425","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.bcp.2023.115694_b0430","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.M112.350108","article-title":"Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors","volume":"287","author":"Holdsworth","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.bcp.2023.115694_b0435","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Semenov","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0440","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00223-008-9130-9","article-title":"The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations","volume":"82","author":"Balemans","year":"2008","journal-title":"Calcif. Tissue Int."},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b0445","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/MCB.01343-14","article-title":"Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast","volume":"35","author":"Frey","year":"2015","journal-title":"Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b0450","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","article-title":"Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo","volume":"4","author":"Choi","year":"2009","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.bcp.2023.115694_b0455","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","article-title":"Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function","volume":"286","author":"Leupin","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.bcp.2023.115694_b0460","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1074\/jbc.RA118.006769","article-title":"Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism","volume":"294","author":"Kim","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0465","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jcb.25432","article-title":"Sclerostin enhances adipocyte differentiation in 3T3-L1 cells","volume":"117","author":"Ukita","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0470","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180011","article-title":"The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus","volume":"38","author":"Liu","year":"2018","journal-title":"Biosci. Rep."},{"issue":"50","key":"10.1016\/j.bcp.2023.115694_b0475","doi-asserted-by":"crossref","first-page":"25950","DOI":"10.1074\/jbc.M116.735373","article-title":"Activation of Wnt signaling in cortical neurons enhances glucose utilization through glycolysis","volume":"291","author":"Cisternas","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115694_b0480","doi-asserted-by":"crossref","first-page":"e13912","DOI":"10.1111\/apha.13912","article-title":"WNT\/\u03b2-catenin pathway is a key regulator of cardiac function and energetic metabolism","author":"Balatskyi","year":"2023","journal-title":"Acta Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0485","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/scd.2020.0141","article-title":"Energy metabolism during osteogenic differentiation: the role of Akt","volume":"30","author":"Smith","year":"2021","journal-title":"Stem Cells Dev."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0490","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physrev.00003.2009","article-title":"Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease","volume":"90","author":"Glatz","year":"2010","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0495","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cmet.2013.03.017","article-title":"WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation","volume":"17","author":"Esen","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2023.115694_b0500","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.3389\/fcell.2021.771336","article-title":"Wnt7b inhibits osteoclastogenesis via AKT activation and glucose metabolic rewiring","volume":"9","author":"Wu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0505","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00261-012-9862-x","article-title":"Causes of obesity","volume":"37","author":"Wright","year":"2012","journal-title":"Abdom. Radiol."},{"issue":"18","key":"10.1016\/j.bcp.2023.115694_b0510","doi-asserted-by":"crossref","first-page":"11547","DOI":"10.1074\/jbc.M114.628487","article-title":"Increasing adipocyte lipoprotein lipase improves glucose metabolism in high fat diet-induced obesity","volume":"290","author":"Walton","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0515","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/joim.12540","article-title":"Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids","volume":"280","author":"Smith","year":"2016","journal-title":"J. Intern. Med."},{"issue":"6\u20137","key":"10.1016\/j.bcp.2023.115694_b0520","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejcb.2013.06.001","article-title":"Adipocyte and adipogenesis","volume":"92","author":"Ali","year":"2013","journal-title":"Eur. J. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0525","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1113\/jphysiol.1934.sp003113","article-title":"Dietetic factors influencing the glucose tolerance and the activity of insulin","volume":"81","author":"Himsworth","year":"1934","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0530","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2337\/diab.31.3.232","article-title":"Decreased insulin binding, glucose transport, and glucose metabolism in soleus muscle of rats fed a high fat diet","volume":"31","author":"Grundleger","year":"1982","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0535","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0021-9150(99)00504-3","article-title":"Relationship of dietary fat to glucose metabolism","volume":"150","author":"Lichtenstein","year":"2000","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.bcp.2023.115694_b0540","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/diab.37.10.1397","article-title":"Alteration of insulin-receptor kinase activity by high-fat feeding","volume":"37","author":"Watarai","year":"1988","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0545","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0026-0495(93)90016-H","article-title":"Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats","volume":"42","author":"Iwanishi","year":"1993","journal-title":"Metab."},{"issue":"9","key":"10.1016\/j.bcp.2023.115694_b0550","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/obr.12298","article-title":"Targeting fatty acid metabolism to improve glucose metabolism","volume":"16","author":"Stinkens","year":"2015","journal-title":"Obes. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0555","first-page":"545","article-title":"Interaction between free fatty acids and glucose metabolism","volume":"5","author":"Boden","year":"2002","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0560","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00033.2003","article-title":"Mechanisms of the free fatty acid-induced increase in hepatic glucose production","volume":"284","author":"Lam","year":"2003","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bcp.2023.115694_b0565","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2337\/diabetes.50.7.1612","article-title":"Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects","volume":"50","author":"Boden","year":"2001","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.bcp.2023.115694_b0570","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.121164498","article-title":"Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance","volume":"98","author":"Kim","year":"2001","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0575","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1152\/ajpendo.00429.2001","article-title":"Metabolism, FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis","volume":"283","author":"Boden","year":"2002","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bcp.2023.115694_b0580","first-page":"e27123","article-title":"An insight into the association of sclerostin with insulin sensitivity and glycemic parameters in male indian prediabetic and diabetic population","volume":"14","author":"Singh","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.bcp.2023.115694_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116682","article-title":"Antibodies to sclerostin or G-CSF receptor partially eliminate bone or marrow adipocyte loss, respectively, following vertical sleeve gastrectomy","volume":"169","author":"Li","year":"2023","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0590","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/nu5030829","article-title":"The role of gut microbiota on insulin resistance","volume":"5","author":"Caricilli","year":"2013","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0595","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00223-021-00899-0","article-title":"Adipose tissue dysfunction: impact on bone and osseointegration","volume":"110","author":"King","year":"2022","journal-title":"Calcif. Tissue Int."},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0600","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/0026-0495(92)90165-7","article-title":"A high-fat diet worsens metabolic control in streptozotocin-treated rats by increasing hepatic glucose production","volume":"41","author":"Traianedes","year":"1992","journal-title":"Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0605","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00572823","article-title":"Long-term fat-feeding-induced insulin resistance in normal NMRI mice: postreceptor changes of liver, muscle and adipose tissue metabolism resembling those of type 2 diabetes","volume":"29","author":"Hedeskov","year":"1992","journal-title":"Acta Diabetol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-11-74","article-title":"ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK","volume":"11","author":"Thyagarajan-Sahu","year":"2011","journal-title":"BMC Complement. Altern. Med."},{"issue":"22","key":"10.1016\/j.bcp.2023.115694_b0615","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1002\/anie.201601973","article-title":"Hamamelitannin analogues that modulate quorum sensing as potentiators of antibiotics against Staphylococcus aureus","volume":"55","author":"Vermote","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0620","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1073\/pnas.0711402105","article-title":"High glucose induces adipogenic differentiation of muscle-derived stem cells","volume":"105","author":"Aguiari","year":"2008","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2023.115694_b0625","doi-asserted-by":"crossref","first-page":"e0199603","DOI":"10.1371\/journal.pone.0199603","article-title":"Selective adipogenic differentiation of human periodontal ligament stem cells stimulated with high doses of glucose","volume":"13","author":"Deng","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0630","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","article-title":"Why does obesity cause diabetes?","volume":"34","author":"Klein","year":"2022","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0635","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5483\/BMBRep.2010.43.2.140","article-title":"High glucose induces differentiation and adipogenesis in porcine muscle satellite cells via mTOR","volume":"43","author":"Yue","year":"2010","journal-title":"BMB Rep."},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b0640","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1002\/jcp.30873","article-title":"Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR-mediated inhibition of autophagy under hyperlipidemic conditions","volume":"237","author":"Oh","year":"2022","journal-title":"J. Cell. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115694_b0645","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-009-0344-6","article-title":"High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP\/protein kinase A\/extracellular signal-regulated kinase pathway","volume":"338","author":"Wang","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"23","key":"10.1016\/j.bcp.2023.115694_b0650","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1073\/pnas.0703407104","article-title":"A high-throughput siRNA library screen identifies osteogenic suppressors in human mesenchymal stem cells","volume":"104","author":"Zhao","year":"2007","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0655","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1089\/ten.tea.2008.0512","article-title":"cAMP\/PKA signaling inhibits osteogenic differentiation and bone formation in rodent models","volume":"15","author":"Siddappa","year":"2009","journal-title":"Tissue Eng. A"},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0660","doi-asserted-by":"crossref","first-page":"e0125667","DOI":"10.1371\/journal.pone.0125667","article-title":"Berberine suppresses adipocyte differentiation via decreasing CREB transcriptional activity","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0665","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41574-021-00471-8","article-title":"Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics","volume":"17","author":"Morigny","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b0670","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/jcb.24607","article-title":"Activation of the PI 3 K\/A kt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts","volume":"114","author":"Zhang","year":"2013","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0675","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/stem.1659","article-title":"Switch from canonical to noncanonical Wnt signaling mediates high glucose-induced adipogenesis","volume":"32","author":"Keats","year":"2014","journal-title":"Stem Cells"},{"issue":"30","key":"10.1016\/j.bcp.2023.115694_b0680","doi-asserted-by":"crossref","first-page":"28430","DOI":"10.1074\/jbc.M103382200","article-title":"Insulin-induced adipocyte differentiation: activation of CREB rescues adipogenesis from the arrest caused by inhibition of prenylation","volume":"276","author":"Klemm","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0685","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/fon.11.145","article-title":"Curcumin molecular targets in obesity and obesity-related cancers","volume":"8","author":"Shehzad","year":"2012","journal-title":"Future Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0690","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/endo.137.8.8754791","article-title":"Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation","volume":"137","author":"Magun","year":"1996","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0695","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/bbrc.1995.1965","article-title":"Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells","volume":"212","author":"Tomiyama","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"50","key":"10.1016\/j.bcp.2023.115694_b0700","doi-asserted-by":"crossref","first-page":"35630","DOI":"10.1074\/jbc.274.50.35630","article-title":"Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis","volume":"274","author":"Engelman","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.bcp.2023.115694_b0705","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1074\/jbc.274.15.10071","article-title":"An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes","volume":"274","author":"Sweeney","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0710","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1152\/ajpregu.00457.2009","article-title":"Insulin and insulin-like growth factor I signaling pathways in rainbow trout (Oncorhynchus mykiss) during adipogenesis and their implication in glucose uptake","volume":"299","author":"Bouraoui","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2023.115694_b0715","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4014\/jmb.1802.01065","article-title":"Acer okamotoanum nakai leaf extract inhibits adipogenesis via suppressing expression of PPAR gamma and C\/EBP alpha in 3T3-L1 Cells","volume":"28","author":"Kim","year":"2018","journal-title":"J. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0720","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11033-020-06036-8","article-title":"Molecular mechanism of down-regulating adipogenic transcription factors in 3T3-L1 adipocyte cells by bioactive anti-adipogenic compounds","volume":"48","author":"Guru","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2023.115694_b0725","doi-asserted-by":"crossref","first-page":"e6189","DOI":"10.1371\/journal.pone.0006189","article-title":"Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0730","doi-asserted-by":"crossref","first-page":"519S","DOI":"10.1093\/ajcn\/67.3.519S","article-title":"Metabolic interactions between glucose and fatty acids in humans","volume":"67","author":"Wolfe","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bcp.2023.115694_b0735","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/549241","article-title":"Functional relationships between lipid metabolism and liver regeneration","volume":"2012","author":"Rudnick","year":"2012","journal-title":"Int. J. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0740","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","article-title":"Adipogenesis and metabolic health","volume":"20","author":"Ghaben","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2023.115694_b0745","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fendo.2011.00085","article-title":"Uncoupling protein 1 of brown adipocytes, the only uncoupler: a historical perspective","volume":"2","author":"Ricquier","year":"2011","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0750","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1194\/jlr.M018846","article-title":"The adipose organ of obesity-prone C57BL\/6J mice is composed of mixed white and brown adipocytes","volume":"53","author":"Vitali","year":"2012","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.bcp.2023.115694_b0755","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nm.3361","article-title":"Brown and beige fat: development, function and therapeutic potential","volume":"19","author":"Harms","year":"2013","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b0760","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrm.2016.96","article-title":"Control of brown and beige fat development","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13105-018-0658-5","article-title":"Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes","volume":"75","author":"Kaisanlahti","year":"2019","journal-title":"J. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0770","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/jcp.25976","article-title":"The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis","volume":"233","author":"Fairfield","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2023.115694_b0775","article-title":"Endocrine functions of sclerostin","volume":"28","author":"Riddle","year":"2022","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"10.1016\/j.bcp.2023.115694_b0780","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fendo.2019.00159","article-title":"Sclerostin antibody mitigates estrogen deficiency-inducted marrow lipid accumulation assessed by proton MR spectroscopy","volume":"10","author":"Li","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0785","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5312\/wjo.v5.i3.242","article-title":"Osteoporosis and obesity: role of Wnt pathway in human and murine models","volume":"5","author":"Colaianni","year":"2014","journal-title":"World J. Orthop."},{"issue":"12","key":"10.1016\/j.bcp.2023.115694_b0790","doi-asserted-by":"crossref","first-page":"E2584","DOI":"10.1210\/jc.2013-4493","article-title":"Circulating sclerostin associated with vertebral bone marrow fat in older men but not women","volume":"99","author":"Ma","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0795","doi-asserted-by":"crossref","first-page":"E1473","DOI":"10.1210\/jc.2012-1218","article-title":"Association of circulating sclerostin levels with fat mass and metabolic disease\u2013related markers in Japanese postmenopausal women","volume":"97","author":"Urano","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0800","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2265.2011.04315.x","article-title":"Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women","volume":"76","author":"Sheng","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0805","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults","volume":"97","author":"Amrein","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000497113","article-title":"The bone markers sclerostin, osteoprotegerin, and bone-specific alkaline phosphatase are related to insulin resistance in children and adolescents, independent of their association with growth and obesity","volume":"91","author":"Stanik","year":"2019","journal-title":"Horm. Res. Paediatr."},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0815","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1515\/jpem-2020-0662","article-title":"Serum sclerostin concentration is associated with specific adipose, muscle and bone tissue markers in lean adolescent females with increased physical activity","volume":"34","author":"J\u00fcrim\u00e4e","year":"2021","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0820","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/nu13020623","article-title":"Circulating levels of sclerostin predict glycemic improvement after sleeve gastrectomy","volume":"13","author":"Carbone","year":"2021","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b0825","doi-asserted-by":"crossref","first-page":"e21957","DOI":"10.1096\/fj.202100691R","article-title":"Bone-derived sclerostin and Wnt\/beta-catenin signaling regulate PDGFRalpha(+) adipoprogenitor cell differentiation","volume":"35","author":"Kim","year":"2021","journal-title":"FASEB J."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2023.115694_b0830","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00508-019-1450-4","article-title":"Diabetes mellitus-definition, classification, diagnosis, screening and prevention (Update 2019)","volume":"131","author":"Harreiter","year":"2019","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.bcp.2023.115694_b0835","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"42","author":"Punthakee","year":"2018","journal-title":"Can. J. Diabetes"},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0840","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes","volume":"97","author":"Gennari","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bcp.2023.115694_b0845","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1210\/jc.2012-1901","article-title":"Sclerostin levels associated with inhibition of the Wnt\/beta-catenin signaling and reduced bone turnover in type 2 diabetes mellitus","volume":"97","author":"Gaudio","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0850","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garcia-Martin","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0855","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cen.13300","article-title":"The association between sclerostin and incident type 2 diabetes risk: a cohort study","volume":"86","author":"Yu","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b0860","doi-asserted-by":"crossref","first-page":"e0206761","DOI":"10.1371\/journal.pone.0206761","article-title":"Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: a case control study","volume":"13","author":"Saadeldin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2023.115694_b0865","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bone.2018.08.007","article-title":"Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus","volume":"120","author":"Wedrychowicz","year":"2019","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0870","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2023.115694_b0875","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bone.2018.07.021","article-title":"Sclerostin and its association with insulin resistance in children and adolescents","volume":"120","author":"Wedrychowicz","year":"2019","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0880","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/EC-20-0535","article-title":"Serum sclerostin is negatively associated with insulin sensitivity in obese but not lean women","volume":"10","author":"Aznou","year":"2021","journal-title":"Endocr. Connect."},{"issue":"9","key":"10.1016\/j.bcp.2023.115694_b0885","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/children8090788","article-title":"Associations between sclerostin and anthropometric and metabolic parameters in children and adolescents","volume":"8","author":"Kim","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.bcp.2023.115694_b0890","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cytogfr.2015.12.009","article-title":"Bone morphogenetic proteins in inflammation, glucose homeostasis and adipose tissue energy metabolism","volume":"27","author":"Grgurevic","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0895","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1038\/s41467-018-07316-5","article-title":"Glucose metabolism induced by Bmp signaling is essential for murine skeletal development","volume":"9","author":"Lee","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0900","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/biof.1334","article-title":"Bone morphogenetic protein-7 (BMP-7) augments insulin sensitivity in mice with type II diabetes mellitus by potentiating PI3K\/AKT pathway","volume":"43","author":"Chattopadhyay","year":"2017","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0905","doi-asserted-by":"crossref","first-page":"17192","DOI":"10.1038\/s41598-017-17595-5","article-title":"BMPs as new insulin sensitizers: enhanced glucose uptake in mature 3T3-L1 adipocytes via PPARgamma and GLUT4 upregulation","volume":"7","author":"Schreiber","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0910","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cmet.2013.01.009","article-title":"LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans","volume":"17","author":"Singh","year":"2013","journal-title":"Cell Metab."},{"issue":"5816","key":"10.1016\/j.bcp.2023.115694_b0915","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1136370","article-title":"LRP6 mutation in a family with early coronary disease and metabolic risk factors","volume":"315","author":"Mani","year":"2007","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bcp.2023.115694_b0920","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00125-007-0656-6","article-title":"Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion","volume":"50","author":"Wang","year":"2007","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0925","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1172\/JCI30706","article-title":"Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes","volume":"117","author":"Lyssenko","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.bcp.2023.115694_b0930","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.2337\/db06-0381","article-title":"Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals","volume":"55","author":"Saxena","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0935","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0940","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00125-006-0521-z","article-title":"TCF7L2 and type 2 diabetes\u2013we WNT to know","volume":"50","author":"Smith","year":"2007","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0945","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.gde.2007.04.003","article-title":"Genetics of type 2 diabetes","volume":"17","author":"Owen","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"5829","key":"10.1016\/j.bcp.2023.115694_b0950","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1126\/science.1142382","article-title":"A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants","volume":"316","author":"Scott","year":"2007","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bcp.2023.115694_b0955","doi-asserted-by":"crossref","first-page":"e8509","DOI":"10.1371\/journal.pone.0008509","article-title":"Activation of Wnt\/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells","volume":"4","author":"Abiola","year":"2009","journal-title":"PLoS One"},{"issue":"158","key":"10.1016\/j.bcp.2023.115694_b0960","doi-asserted-by":"crossref","first-page":"ra6","DOI":"10.1126\/scisignal.2001249","article-title":"Wnt signaling regulates hepatic metabolism","volume":"4","author":"Liu","year":"2011","journal-title":"Sci. Signal."},{"issue":"15","key":"10.1016\/j.bcp.2023.115694_b0965","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1073\/pnas.0701509104","article-title":"Wnt signaling regulates pancreatic \u03b2 cell proliferation","volume":"104","author":"Rulifson","year":"2007","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b0970","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1073\/pnas.0133792100","article-title":"Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion","volume":"100","author":"Fujino","year":"2003","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b0975","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/db06-1339","article-title":"Wnt10b inhibits obesity in ob\/ob and agouti mice","volume":"56","author":"Wright","year":"2007","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b0980","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/cen.12364","article-title":"Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus","volume":"80","author":"Neumann","year":"2014","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b0985","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2016-2371","article-title":"High sclerostin and dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus","volume":"102","author":"Faienza","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2023.115694_b0990","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-14-0106","article-title":"Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus","volume":"171","author":"Catalano","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b0995","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jdiacomp.2019.04.012","article-title":"Serum sclerostin level and its relation to subclinical atherosclerosis in subjects with type 2 diabetes","volume":"33","author":"Shalash","year":"2019","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.bcp.2023.115694_b1000","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4596920","article-title":"Serum sclerostin, body composition, and sarcopenia in hemodialysis patients with diabetes","volume":"2020","author":"Medeiros","year":"2020","journal-title":"Int. J. Nephrol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b1005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/EJE-11-1061","article-title":"Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus","volume":"166","author":"Van Lierop","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b1010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","article-title":"Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes","volume":"56","author":"Ardawi","year":"2013","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bcp.2023.115694_b1015","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2013-2143","article-title":"Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus","volume":"98","author":"Yamamoto","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b1020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40610-017-0061-y","article-title":"Sclerostin and Adipose Tissue","volume":"3","author":"Fulzele","year":"2017","journal-title":"Curr. Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b1025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00223-016-0229-0","article-title":"Obesity, type 2 diabetes and bone in adults","volume":"100","author":"Walsh","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b1030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jocd.2014.09.005","article-title":"Obesity and fractures in postmenopausal women: a primary-care cross-sectional study at Santa Maria, Brazil","volume":"18","author":"Copes","year":"2015","journal-title":"J. Clin. Densitom."},{"issue":"2","key":"10.1016\/j.bcp.2023.115694_b1035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1359\/jbmr.091004","article-title":"Obesity and fractures in postmenopausal women","volume":"25","author":"Premaor","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bcp.2023.115694_b1040","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.dsx.2019.07.036","article-title":"The prevalence of osteoporosis among Iranian postmenopausal women with type 2 diabetes: A systematic review and meta-analysis","volume":"13","author":"Parizad","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"issue":"11","key":"10.1016\/j.bcp.2023.115694_b1045","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bcp.2023.115694_b1050","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00125-022-05715-4","article-title":"Management of type 2 diabetes with the dual GIP\/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis","volume":"65","author":"Karagiannis","year":"2022","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.bcp.2023.115694_b1055","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.3390\/ijms22126578","article-title":"Effects of incretin-related diabetes drugs on bone formation and bone resorption","volume":"22","author":"Kitaura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115694_b1060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2023.115694_b1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115121","article-title":"Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis","volume":"130","author":"Lv","year":"2020","journal-title":"Bone"},{"issue":"15","key":"10.1016\/j.bcp.2023.115694_b1070","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115694_b1075","first-page":"1","article-title":"Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation","volume":"13","author":"Yu","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bcp.2023.115694_b1080","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/dc18-0918","article-title":"Effects of high blood pressure on cardiovascular disease events among Chinese adults with different glucose metabolism","volume":"41","author":"Tian","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.bcp.2023.115694_b1085","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2022.01.012","article-title":"Drug discovery of sclerostin inhibitors","volume":"12","author":"Yu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"13","key":"10.1016\/j.bcp.2023.115694_b1090","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.7150\/thno.63177","article-title":"Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522300285X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522300285X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:19:33Z","timestamp":1762096773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522300285X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":218,"alternative-id":["S000629522300285X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115694","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of sclerostin in lipid and glucose metabolism disorders","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115694"}}